Pituitary adenoma in patients with multiple endocrine neoplasia type 1 - a cohort study

CONCLUSION: PAs in patients with MEN1 are less aggressive than previously thought. Tumour progression is rare with standard of care monitoring and treatment, especially in related patients who mostly present non-secreting microadenoma. MRI monitoring for asymptomatic MEN1 patients should be reduced accordingly.PMID:34636744 | DOI:10.1530/EJE-21-0630
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Source Type: research